Price T Rowe Associates Inc Cassava Sciences Inc Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 36,366 shares of SAVA stock, worth $88,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,366

Previous 35,334 2.92%

Holding current value

$88,005

Previous $1.04 Million 91.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.29 - $32.18 $2,363 - $33,209	1,032 Added 2.92%	36,366 $86,000
Q3 2024 Nov 14, 2024	BUY	$9.57 - $35.08 $5,263 - $19,294	550 Added 1.58%	35,334 $1.04 Million
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $42,693 - $90,262	3,457 Added 11.04%	34,784 $430,000
Q1 2024 May 15, 2024	BUY	$18.44 - $26.41 $26,848 - $38,452	1,456 Added 4.87%	31,327 $636,000
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $28,844 - $68,711	2,282 Added 8.27%	29,871 $673,000
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $14,476 - $22,028	870 Added 3.26%	27,589 $460,000
Q2 2023 Aug 14, 2023	SELL	$21.59 - $27.88 $5,354 - $6,914	-248 Reduced 0.92%	26,719 $656,000
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $36,738 - $57,065	1,566 Added 6.17%	26,967 $651,000
Q4 2022 Feb 14, 2023	SELL	$27.82 - $44.16 $66,211 - $105,100	-2,380 Reduced 8.57%	25,401 $750,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $15,170 - $47,434	929 Added 3.46%	27,781 $1.16 Million
Q2 2022 Aug 15, 2022	SELL	$17.22 - $38.47 $23,987 - $53,588	-1,393 Reduced 4.93%	26,852 $755,000
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $174,214 - $283,499	5,344 Added 23.34%	28,245 $1.05 Million
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $60,266 - $149,001	1,639 Added 7.71%	22,901 $1 Million
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $27,038 - $87,539	-647 Reduced 2.95%	21,262 $1.32 Million
Q2 2021 Aug 16, 2021	SELL	$32.15 - $89.72 $443,573 - $1.24 Million	-13,797 Reduced 38.64%	21,909 $1.87 Million
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $157,461 - $1.95 Million	22,209 Added 164.55%	35,706 $1.61 Million
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $91,644 - $165,338	13,497 New	13,497 $92,000

Others Institutions Holding SAVA

# of Institutions

189

Shares Held

16M

Call Options Held

3.7M

Put Options Held

8.77M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $97M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Cassava Sciences Inc Transaction History